HPE 101

Known as: HPE-101 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
We evaluated a needle-free injector (NFI), which has been studied as an administration device to the subcutaneous tissue, as a… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2006
2006
The influence of skin permeation enhancers, such as dimethyl sulphoxide (DMSO) and 1-[2-(decylthio)ethyl]azacyclopentan-2-one… (More)
  • figure 1
Is this relevant?
2004
2004
The primary aim of this study was to investigate the skin permeation-enhancing mechanism of HPE-101 using erythrocyte ghost cells… (More)
Is this relevant?
1996
1996
The purpose of this study was to evaluate the effect of absorption enhancer on in-vivo transdermal absorption of cyclosporin… (More)
Is this relevant?
1994
1994
Microdialysis was applied to determine the in vivo transdermal absorption of methotrexate (MTX) in rats with or without a new… (More)
Is this relevant?
1994
1994
The suitability of sampling via microdialysis for a lipophilic drug, valproate (VPA), was evaluated by the elimination rate… (More)
Is this relevant?
1993
1993
The penetration enhancer, 1-[2-(decylthio)ethyl]azacyclopentan-2-one (HPE-101), significantly enhanced the excretion of topically… (More)
Is this relevant?
1992
1992
A new compound, 1-[2-(decylthio)ethyl]azacyclopentan-2-one (HPE-101) was synthesized, and its skin penetration enhancing activity… (More)
Is this relevant?
1992
1992
Prostaglandin E1 (PGE1) and its inclusion complexes with beta-cyclodextrin (beta-CyD) and O-carboxymethyl-O-ethyl-beta… (More)
Is this relevant?
1992
1992
The optimal prescription of transdermal preparations of prostaglandin E1 (PGE1) for treatment of peripheral vascular diseases has… (More)
Is this relevant?